Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction

Korean Journal of Internal Medicine

Volumn 25, Issue 1, 2010, Pages 44-50

  Biswas, Santanu ^a   Ghoshal, Pradip K ^b   Mandal, Sankar C ^b,c   Mandal, Nripendranath ^a  

^a BOSE INSTITUTE   (India)

^b NRS Medical College and Hospital   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cytokines, inflammatory; Myocardial infarction, acute; ROC curve

Indexed keywords

CHOLESTEROL; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 77949379503     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2010.25.1.44     Document Type: Article

References (26)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardio-vascular disease in women. N Engl J Med 2000;342:836-843.
3. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infraction: the Framingham Heart Study. Circulation 2003;107: 1486-1491.
4. Piche ME, Lemieux S, Weisnagel SJ, Cornean L, Nadean A, Bengeron J. Relation of high sensitivity C-reactive protein, interleukin-6, tumor factor- alpha and fibrinogen to abdominal, adipose tissue, blood pressure and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96:92-97.
5. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011.
6. Baumann H, Gaudie J. The acute phase response. Immunol Today 1994;15:74-80.
7. Papanicolaou DA, Wilder RL, Manologa SC, Chrousos GP. The pathophysiologic roles of interleukine-6 in human disease. Ann Intern Med 1998;128:127-137.
8. Blake GJ, Ridker PM. Novel Clinical markers of vascular wall inflammation. Circ Res 2001;89:763-771.
9. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-1890.
10. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukine- 10 in atherosclerosis. Circ Res 1999;85:e17-e24.
11. Moore KW, de Waal-Malefyt R, Coffiman RL, O'Gara A. Interleukine- 10 and interleukine-10 receptor. Annu Rev Immol 2001;19:683-765.
12. Friedewald WT, Levey RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
13. Feingold K, Grunfeld C. Role of cytokines in inducing hyperlipidaemia. Diabetes 1992;41(Suppl 2):97-101.
14. Hotamisgli G, Shargill N, Spiegelman B. Adipose expression of tumor necrosis factor alpha: direct role in obesity linked insulin resistance. Science 1993;259:87-91.
15. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotension II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378.
16. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukine-6 the link? Atherosclerosis 2000;148:209-214.
17. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-277.
18. Marx N, Neumann FJ, Ott I, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997;30:165-170.
19. Ross R. Atherosclerosis: as inflammatory disease. N Engl J Med 1999;340:115-126.
20. Serneri GG, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790-797.
21. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int 1996;29:55-64.
22. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukine (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995;270:9558-9563.
23. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A. Expression of interleukine-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999;19:611-616.
24. Ito T, Ikeda U. Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2003;2:257-265.
25. Yamaoka M, Yamaguchi S, Okuyama M, Tomoike H. Antiinflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Circ J 1999;63:951-956.
26. Kurtzhals J, Adabayeri V, Goka BQ, et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998;351:1768-1772.